Here are relevant reports on : diagnostic-imaging-services-market
-
Ultrasound Needle Guides Market by Type (Reusable, Disposable), Application (Tissue Biopsy, Fluid Aspiration, Nerve Block, Regional Anesthesia, Vascular Access), End User (Hospitals, Clinics, ASC, Diagnostic Imaging Centers) & Region - Global Forecasts to 2027
The global ultrasound needle guides market, stood at US$274 million in 2022 and is projected to advance at a resilient CAGR of 6.1% from 2022 to 2028, culminating in a forecasted valuation of US$369 billion by the end of the period. Ultrasound needle guides have applications in the diagnosis and treatment of diseases such as cancer and CVD. The prevalence of these target diseases is increasing across the globe due to factors such as the rising geriatric population and the increasing adoption of sedentary lifestyles.
- Published: February 2023
- Price: $ 4950
- TOC Available:
-
Mammography Detector Market by type (analog and digital detectors) by technology (DC and IC detectors) by end-user (hospitals, diagnostic imaging centers, and others) and by Region - Global Forecast to 2030
The major players in the global Mammography Detector Market
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Neurodiagnostics Market by Product (Diagnostic & Imaging Systems (MRI, Ultrasound), Clinical Testing (PCR, NGS), Reagents & Consumables), Disease Pathology (Epilepsy, Stroke), End User and Region - Global Forecasts to 2024
The neurodiagnostics market is projected to reach USD 8.4 billion by 2024, at a CAGR of 7.3%. Some of the prominent players in this market includes GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Hitachi, Ltd. (Japan), Canon, Inc. (Japan), Lifelines Neuro Company, LLC (US), Natus Medical Incorporated (US), Hoffman-La Roche AG (Switzerland), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd. (Russia), Advanced Brain Monitoring (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories (US), QIAGEN N.V. (Netherlands), Nihon Kohden Corporation (Japan), ANT Neuro (Netherlands), Fonar Corporation (US), Fujirebio (Japan), DRG Instruments GmbH (Germany), Tecan Trading AG (Switzerland), Motion Lab Systems, Inc. (US), Rigaku Corporation (Japan), Neusoft Medical Systems Co., Ltd. (US), ELMIKO MEDICAL Sp. Z o.o. (Poland) and Ridge Diagnostics (US).
- Published: December 2019
- Price: $ 4950
- TOC Available:
-
AI Agents in Healthcare Market by Function (Scheduling, Billing, Diagnostic, Treatment, RPM, Telehealth), Offering (Multi-Agent), Architecture (Contextual, Conversational), End User (Hospital, ACS, Imaging Center), Trends, Growth - Global Forecast to 2030
The global AI Agents in Healthcare market, valued at US$0.76 billion in 2024, stood at US$1.11 billion in 2025 and is projected to advance at a resilient CAGR of 44.1% from 2025 to 2030, culminating in a forecasted valuation of US$6.92 billion by the end of the period. Advances in generative AI, natural language processing, and seamless integration with electronic health records (EHRs) are enabling AI agents to handle a range of tasks, from patient engagement and appointment scheduling to clinical decision support and documentation assistance.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Biopsy Devices Market by Product (Core needle biopsy (Automatic, Disposable), Technology (Ultrasound,stereotactic), Application (Oncology, Gastroenterology, Bone & Bone marrow biopsy), End User (Diagnostic imaging centres) - Global Forecast to 2030
The global biopsy devices market, valued at US$6.86B in 2023, is forecasted to grow at a 7.2% CAGR, reaching US$7.27B by 2024 and US$11.01B by 2030. The rising prevalence of cancer. Additionally the increasing preference for minimally invasive surgeries. Moreover, the improved reimbursement policies is likely to promote the growth of biopsy device market.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Lymphedema Diagnostics Market by Technology (Lymphoscintigraphy, MRI, Near IR Fluorescence Imaging, Ultrasound), Disease Type (Cancer, Inflammatory Diseases, Cardiovascular, Filariasis), End User (Hospitals, Diagnostic Centers) - Global Forecasts to 2024
The Lymphedema Diagnostics Market is expected to grow from USD 24 million in 2019 to USD 35 million by 2024, at a CAGR of 7.4% during the forecast period. The major players operating in the lymphedema diagnostics market are GE Healthcare (US), Philips (Netherlands), and Siemens Healthineers (Germany). Other prominent players in this market include Canon, Inc. (Japan), Shimadzu Corporation (Japan), Stryker Corporation (US), Fluoptics (France), United Imaging Healthcare Co., Ltd. (China), Hitachi, Ltd. (Japan), Esaote, SpA (Italy), Neusoft Corporation (China), Mindray Medical International, Ltd. (China), Mitaka USA, Inc. (US), Curadel, LLC (US), and ImpediMed Ltd. (Australia).
- Published: October 2019
- Price: $ 4950
- TOC Available:
-
Microscope Camera Market by Type (Color, Monochrome), Sensor (CMOS, CCD), Resolution (SD, HD, UHD), Application (Live Cell Imaging, Pathology, Pharmaceutical & Biopharmaceutical Research), End User (Hospitals, Diagnostic Labs) - Global Forecast to 2029
The global microscope camera market, valued at US$178 million in 2023, stood at US$191 million in 2024 and is projected to advance at a resilient CAGR of 7.8% from 2024 to 2029, culminating in a forecasted valuation of US$278 million by the end of the period. Growth in this market is mainly driven by factors such as the growing prevalence of chronic diseases and advancing technological aspects in microscope cameras. Growth opportunities in the Asia Pacific region are also expected to leverage a positive environment for players playing in the microscope camera market.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Patient Positioning Systems Market Size by Product (Tables (Surgical Table, Imaging Table, Examination Table), Accessories, Application (Surgery, Diagnosis, Cancer Treatment), End User (Hospitals, ASCs, Diagnostic Labs)) & Region - Global Forecast to 2027
The global patient positioning systems market growth is primed to transition from USD 1.4 billion in 2022 to USD 1.7 billion by 2027, showcasing a strong CAGR of 4.0%. Growth of the market is attributed to the increasing preference for minimally invasive surgeries and rising funding for new healthcare facility establishment.
- Published: January 2023
- Price: $ 4950
- TOC Available:
-
North America Dental Equipment Market by Product [Therapeutic (Dental Chairs, Dental Units, CAD/CAM, Dental Lasers), Diagnostic (Dental imaging, CBCT)], End User (Dental Hospitals & Dental Clinics) - Forecast to 2031
The North America Dental Equipment market, valued at USD 2.23 billion in 2025, stood at USD 2.47 billion in 2026 and is projected to advance at a resilient CAGR of 5.3% from 2026 to 2031, culminating in a forecasted valuation of USD 3.37 billion by the end of the period. The North America dental equipment market is driven by rapid advances in digital and clinical dental technologies, along with a growing burden of oral health disorders.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Breast Lesion Localization Market by Type (Wire, Radioisotope (ROLL, RSL), Magnetic, Electromagnetic Localization), Usage (Breast Biopsy, Lumpectomy), End User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers) - Global Forecast to 2028
The global breast lesion localization market, valued at US$0.2 billion in 2022, stood at US$0.3 billion in 2023 and is projected to advance at a resilient CAGR of 6.9% from 2023 to 2028, culminating in a forecasted valuation of US$0.4 billion by the end of the period. The increasing number of breast cancer screening programs and improved reimbursement scenarios are expected to drive market growth. Additionally, the rising number of breast cancer surgeries and increasing awareness of early detection are further supporting the growth of this market.
- Published: July 2023
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
